McKesson Corporation

MCK

US58155Q1031

Pharmaceuticals

Market Closed - Nyse Other stock markets 04:00:02 2024-07-09 pm EDT			5-day change	1st Jan Change
586.8 ^USD	-0.46%		+0.34%	+26.75%

Jul. 09	AMN Healthcare Appoints Jim Hinton to Board of Directors Effective July 22	CI
Jul. 09	Baird Adjusts McKesson's Price Target to $694 From $679, Keeps Outperform Rating	MT

McKesson Corporation announces an Increase in Equity Buyback.

January 31, 2020

In January 2021, the company announced an increase in its equity buyback plan. The company increase the repurchase authorization by $2,000 million.

Latest news about McKesson Corporation

AMN Healthcare Appoints Jim Hinton to Board of Directors Effective July 22	Jul. 09	CI
Baird Adjusts McKesson's Price Target to $694 From $679, Keeps Outperform Rating	Jul. 09	MT
Evercore ISI Adjusts Price Target on McKesson to $660 From $600, Maintains Outperform Rating	Jul. 09	MT
Mckesson Insider Sold Shares Worth $2,180,193, According to a Recent SEC Filing	Jul. 08	MT
Leerink Adjusts Price Target on McKesson to $700 From $617, Maintains Outperform Rating	Jul. 08	MT
Rhia Ventures Files an Exempt Solicitation Statement and Request Vote for the Proposal	Jun. 28	CI
Sector Update: Consumer Stocks Mixed in Late Afternoon Trading	Jun. 27	MT
Rite Aid seeks bankruptcy court approval to cut $2 billion debt	Jun. 27	RE
Independent Pharmacy Cooperative Announces New Supply Agreement with McKesson	Jun. 24	CI
Argus Adjusts Price Target on McKesson to $670 From $570	Jun. 24	MT
McKesson Corporation Receives a Shareholder Proposal from Rhia Ventures	Jun. 21	CI
McKesson Corporation Receives a Shareholder Proposal from John Chevedden	Jun. 21	CI
Deutsche Bank Adjusts Price Target on McKesson to $631 From $545	Jun. 14	MT
Mckesson Insider Sold Shares Worth $351,318, According to a Recent SEC Filing	Jun. 12	MT
Top law firms in US opioid lawsuits to get hundreds of millions in fees	Jun. 07	RE
Mckesson Insider Sold Shares Worth $2,155,761, According to a Recent SEC Filing	Jun. 06	MT
Mckesson Insider Sold Shares Worth $2,935,100, According to a Recent SEC Filing	Jun. 03	MT
Mckesson Corporation Elects Deborah Dunsire as New Director	Jun. 03	CI
McKesson Insider Sold Shares Worth $1,833,166, According to a Recent SEC Filing	May. 30	MT
Baird Adjusts Price Target on McKesson to $679 From $671	May. 29	MT
Mckesson Insider Sold Shares Worth $392,895, According to a Recent SEC Filing	May. 28	MT
Mckesson Insider Sold Shares Worth $7,116,764, According to a Recent SEC Filing	May. 28	MT
JPMorgan Adjusts McKesson Price Target to $656 From $589	May. 17	MT
McKesson Seeks Acquisitions	May. 16	CI
Transcript : McKesson Corporation Presents at Bank of America Health Care Conference 2024, May-16-2024 09:20 AM	May. 16

McKesson Corporation specializes in pharmaceutical product distribution. The group also offers technological services to healthcare companies. Net sales break down by activity as follows: - distribution of pharmaceutical products (87%); - distribution of medical and surgical products (4%); - other (1.6%): primarily technology services and software sales. The remaining net sales (7.4%) are from international activities.

Sector

Pharmaceuticals

Calendar

2024-07-31 - Annual General Meeting

Related indices

S&P 500

More about the company

Income Statement Evolution

More financial data

Ratings for McKesson Corporation

Trading Rating

Investor Rating

ESG Refinitiv

C+

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

586.8 USD

Average target price

609.8 USD

Spread / Average Target

+3.91%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Pharmaceuticals Wholesale

	1st Jan change	Capi.
MCKESSON CORPORATION	+26.75%	76.12B
SHANGHAI PHARMACEUTICALS HOLDING CO., LTD	+14.58%	8.69B
SINOPHARM GROUP CO. LTD.	-4.45%	7.91B
HUADONG MEDICINE CO., LTD	-35.36%	6.45B
H. LUNDBECK A/S	+23.93%	5.75B
GALENICA AG	+2.68%	4.16B
EBOS GROUP LIMITED	-7.24%	3.89B
JOINTOWN PHARMACEUTICAL GROUP CO., LTD	-12.59%	3.21B
MEDIPAL HOLDINGS CORPORATION	+12.84%	3.25B
CHINA NATIONAL MEDICINES CORPORATION LTD.	+6.85%	3.17B

Pharmaceuticals Wholesale